Johnson & Johnson (NYSE: JNJ) today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
The top elections official in Kansas is running for governor after building his public profile by pushing back against unfounded election conspiracy theories and breaking with fellow Republicans on ...